bioRxivBiochemistryPreprint
An IMPDH2 variant associated with neurodevelopmental disorder disrupts purine biosynthesis and somitogenesis
Audrey G. O’NeilliD, Morgan E. McCartneyiD, Gavin M. WheeleriD, Jeet H. PateliD, Gardenia Sanchez-RamireziD, Justin M. KollmaniD, Andrea Elizabeth WillsiD
- Citations
- 0
Abstract
IMP dehydrogenase (IMPDH) controls a key regulatory node in purine biosynthesis. Gain-of-function mutations in human IMPDH2 are associated with neurodevelopmental disorders and neuromuscular symptoms including dystonia, but the developmental mechanisms underlying these defects are unknown. We previously showed that these mutants are insensitive to GTP inhibition and hypothesized that their hyperactivity would affect nucleotide metabolism in vivo. Here, we characterize the metabolic and developmental consequences of the neurodevelopmental disorder-associated IMPDH2 mutant, S160del, in Xenopus tropicalis. We show that expressing S160del but not WT human IMPDH2 disrupts purine pools and somitogenesis in the developing tadpole. We also show that S160del disrupts in vivo IMPDH filament assembly, a well-described IMPDH regulatory mechanism. Cryo-EM structures show that S160del disrupts filament assembly by destabilizing the dimerization of regulatory Bateman domains. Dimerization of Bateman domains and subsequent filament formation can be restored with a high affinity ligand, but this does not restore sensitivity to GTP inhibition, suggesting S160del also disrupts allostery of IMPDH2 filaments. This work demonstrates that the structural effects of patient IMPDH2 variants can cause disruptions both to nucleotide levels and to the normal development of sensorimotor structures, helping us better understand the physiological basis of disease in these patients. SIGNIFICANCE STATEMENTIMPDH2 is a critical enzyme for de novo purine biosynthesis, regulating the balance between adenine and guanine nucleotides. Under purine stress, it forms filaments that resist feedback inhibition by GTP. Patients with gain-of-function variants of this enzyme suffer from early-onset neuromotor symptoms including dystonia. Here, we express one gain-of-function variant of IMPDH2, S160del, in Xenopus tropicalis. S160del is particularly powerful for structural and developmental studies, as it impedes filament formation and also is insensitive to feedback inhibition by GTP. Here, we show S160del can perturb vertebrate development, metabolism, and filament formation in a dominant fashion. Insights from this work will open the door to a new suite of studies defining the function of purine metabolism in development and disease.
- organism: Xenopus
- assay: proteomics
- research focus: development & morphogenesis
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Point mutations in IMPDH2 which cause early-onset neurodevelopmental disorders disrupt enzyme regulation and filament structure
A. G. O'Neill, A. L. Burrell, … J. M. Kollman·bioRxiv·Mar 15, 2023
- IMPDH1 retinal variants control filament architecture to tune allosteric regulation
A. L. BURRELL, C. Nie, … J. M. Kollman·bioRxiv·Aug 3, 2021
- Appendage regeneration requires IMPDH2 and creates a sensitized environment for enzyme filament formation
Morgan E. McCartney, Gavin M. Wheeler, … Andrea Elizabeth Wills·bioRxiv·Jul 29, 2024
- Light-sensitive phosphorylation regulates enzyme activity and filament assembly of human IMPDH1 retinal splice variants
S. J. Calise, A. G. O'Neill, … J. M. Kollman·bioRxiv·Sep 21, 2023
- Ensemble cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation
Matthew Camp Johnson, Justin M. Kollman·eLifePeer-reviewed·Jan 30, 2020
- IMPDH polymers accommodate both catalytically active and inactive conformations
S. Anthony, A. L. Burrell, … J. R. Peterson·bioRxiv·Jun 19, 2017